ScholarLens Back to search
1999•Chinese Journal of New Drugs and Clinical RemediesRequires access

Efficacy and safety of amlodipine on renal hypertension

Ding Xiao

Open publisher page 0 citations

Abstract

AIM: To evaluate the efficacy and safety of amlodipine on renal hypertension. METHODS: Renal hypertensive 96 patients were divided into amlodipine group [n=54, M 30, F 24; age (38±s 19) a] were given 10 mg, po, qm×6 wk; and combined group [n=42, M 26, F 16; age (41±20) a] were given enalapril 10_20 mg, po, qm×6 wk, and with amlodipine was the same as described above. RESULTS: The total effective rate were 80% and 98% with only (42% and 80% for severe hypertension) in amlodipine group and combined group, respectively(P0.01). CONCLUSION: Amlodipine is effective and safe for the treament of mild or moderate renal hypertension, it is necessary to combine with enalapril to treat severe ranal hypertension.

About this research paper

What this paper is about

AIM: To evaluate the efficacy and safety of amlodipine on renal hypertension. METHODS: Renal hypertensive 96 patients were divided into amlodipine group [n=54, M 30, F 24; age (38±s 19) a] were given 10 mg, po, qm×6 wk; and combined group [n=42, M 26, F 16; age (41±20) a] were given enalapril 10_20 mg, po, qm×6 wk, and with amlodipine was the same as described above. RESULTS: The total effective rate were 80% and 98% with only (42% and 80% for severe hypertension) in amlodipine group and combined group, respectively(P0.01). CONCLUSION: Amlodipine is effective and safe for the treament of mild or moderate renal hypertension, it is necessary to combine with enalapril to treat severe ranal hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To evaluate the efficacy and safety of amlodipine on renal hypertension. METHODS: Renal hypertensive 96 patients were divided into amlodipine group [n=54, M 30, F 24; age (38±s 19) a] were given 10 mg, po, qm×6 wk; and combined group [n=42, M 26, F 16; age (41±20) a] were given enalapril 10_20 mg, po, qm×6 wk, and with amlodipine was the same as described above. RESULTS: The total effective rate were 80% and 98% with only (42% and 80% for severe hypertension) in amlodipine group and combined group, respectively(P0.01). CONCLUSION: Amlodipine is effective and safe for the treament of mild or moderate renal hypertension, it is necessary to combine with enalapril to treat severe ranal hypertension.

Key concepts: Amlodipine, Enalapril, Medicine, Urology, Internal medicine, Essential hypertension, Blood pressure, Angiotensin-converting enzyme

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Efficacy and safety of amlodipine on renal hypertension — Research Paper | ScholarLens